Skip to content

Insider · CIK 0001438538

Catherine M. Szyman

director

Files at NARI (Inari Medical, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 19, 2025NARI
Inari Medical, Inc.
UTender of shares
Common Stock
-22,429--0Feb 19, 2025
Feb 19, 2025NARI
Inari Medical, Inc.
DDisposition to issuer
Stock Optionderivative
-49,719--0Feb 19, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Catherine M. Szyman: insider trades and track record | InsiderTell